Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome
- PMID: 8250811
Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome
Abstract
Activation of the endothelium by TNF or IL-1 results in altered haemostatic properties of and leukocyte binding to the endothelium. In haemolytic uraemic syndrome, the endothelium of the kidney and sometimes other tissues is severely damaged, presumably by a bacterial toxin, verotoxin (VT). In vitro studies have demonstrated that endothelial cells become sensitive to this toxin when they are exposed to TNF alpha or IL-1, inflammatory mediators which are produced by monocytes and mesangial cells and which may play a role in the kidney. In this report we demonstrate the influence of inflammatory mediators on the binding of VT to endothelial cells. Preincubation of human endothelial cells with TNF alpha for 24 h resulted in a ten- to hundred-fold increase of specific binding sites for 125I-VT-1. IL-1 and lymphotoxin (TNF beta) also markedly increased VT-1 binding. An exposure of only 6 h to TNF alpha was already enough to enhance the number of VT-1 binding sites on endothelial cells for at least 2 days. In order to demonstrate that the increases in VT binding was due to an increase in the functional VT receptor, glycolipid extracts of TNF alpha-treated cells were analyzed by thin layer chromatography. An increase of globotriaosylceramide (Gb3) was observed, suggesting that that preincubation of endothelial cells with TNF alpha leads to an increase in Gb3 synthesis in these cells. Inhibition of protein synthesis by cycloheximide prevented the increase in VT receptors induced by TNF alpha.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.Blood. 1992 Dec 1;80(11):2755-64. Blood. 1992. PMID: 1333300
-
Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C.Blood. 1995 Feb 1;85(3):734-43. Blood. 1995. PMID: 7530504
-
Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents.J Infect Dis. 1999 Oct;180(4):1205-13. doi: 10.1086/314982. J Infect Dis. 1999. PMID: 10479149
-
Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.Biochim Biophys Acta. 1999 Oct 8;1455(2-3):375-86. doi: 10.1016/s0925-4439(99)00062-9. Biochim Biophys Acta. 1999. PMID: 10571026 Review.
-
Verotoxin/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia.Biosci Rep. 1999 Oct;19(5):345-54. doi: 10.1023/a:1020299819637. Biosci Rep. 1999. PMID: 10763802 Review.
Cited by
-
Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.Infect Immun. 1999 Mar;67(3):1439-44. doi: 10.1128/IAI.67.3.1439-1444.1999. Infect Immun. 1999. PMID: 10024592 Free PMC article.
-
Hemolytic uremic syndrome: toxins, vessels, and inflammation.Front Med (Lausanne). 2014 Nov 4;1:42. doi: 10.3389/fmed.2014.00042. eCollection 2014. Front Med (Lausanne). 2014. PMID: 25593915 Free PMC article. Review.
-
Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.J Korean Med Sci. 2005 Aug;20(4):548-54. doi: 10.3346/jkms.2005.20.4.548. J Korean Med Sci. 2005. PMID: 16100442 Free PMC article.
-
Shiga toxin pathogenesis: kidney complications and renal failure.Curr Top Microbiol Immunol. 2012;357:105-36. doi: 10.1007/82_2011_172. Curr Top Microbiol Immunol. 2012. PMID: 21983749 Free PMC article. Review.
-
Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.Clin Exp Immunol. 2000 Jan;119(1):77-83. doi: 10.1046/j.1365-2249.2000.01103.x. Clin Exp Immunol. 2000. PMID: 10606967 Free PMC article.